Your browser doesn't support javascript.
loading
Development of MVA-d34 Tetravalent Dengue Vaccine: Design and Immunogenicity.
Mintaev, Ramil R; Glazkova, Dina V; Orlova, Olga V; Ignatyev, Georgiy M; Oksanich, Alexey S; Shipulin, German A; Bogoslovskaya, Elena V.
Afiliación
  • Mintaev RR; Federal State Budgetary Institution "Centre for Strategic Planning and Management of Biomedical Health Risks" of the Federal Medical Biological Agency, 119833 Moscow, Russia.
  • Glazkova DV; Federal State Budgetary Institution "Centre for Strategic Planning and Management of Biomedical Health Risks" of the Federal Medical Biological Agency, 119833 Moscow, Russia.
  • Orlova OV; Federal State Budgetary Institution "Centre for Strategic Planning and Management of Biomedical Health Risks" of the Federal Medical Biological Agency, 119833 Moscow, Russia.
  • Ignatyev GM; Federal State Budgetary Institution "Centre for Strategic Planning and Management of Biomedical Health Risks" of the Federal Medical Biological Agency, 119833 Moscow, Russia.
  • Oksanich AS; I. Mechnikov Research Institute of Vaccines and Sera, 105064 Moscow, Russia.
  • Shipulin GA; Federal State Budgetary Institution "Centre for Strategic Planning and Management of Biomedical Health Risks" of the Federal Medical Biological Agency, 119833 Moscow, Russia.
  • Bogoslovskaya EV; Federal State Budgetary Institution "Centre for Strategic Planning and Management of Biomedical Health Risks" of the Federal Medical Biological Agency, 119833 Moscow, Russia.
Vaccines (Basel) ; 11(4)2023 Apr 12.
Article en En | MEDLINE | ID: mdl-37112743
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: Vaccines (Basel) Año: 2023 Tipo del documento: Article País de afiliación: Rusia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: Vaccines (Basel) Año: 2023 Tipo del documento: Article País de afiliación: Rusia